Francisco Zornosa, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 S Oakwood Rd, Oshkosh, WI 54904 Phone: 920-223-1000 |
News Archive
New research shows that residents of the Stroke Belt—a southern portion of the U.S. with significantly elevated stroke morality rate—also have a greater incidence of cognitive decline than other regions of the country. Researchers believe shared risk factors among members of this population are to blame. Results of this study, funded by the National Institute of Neurological Disorders and Stroke (NINDS), are published in Annals of Neurology, a journal of the American Neurological Association.
Abilities Neurological Rehabilitation is excited to announce a new, collaborative treatment program to help individuals in the Fraser Valley who are living with chronic physical and cognitive symptoms following brain injury.
Akorn, Inc., a niche generic pharmaceutical company, today announced that its wholly-owned subsidiary, Oak Pharmaceuticals, has acquired three off-patent, branded, hospital-based injectables from the US subsidiary of H. Lundbeck A/S.
During surgical removal of thyroid tissue suspicious for cancer, fast, reliable, and cost-effective techniques are needed to analyze the resected tissue for biomarkers—including BRAF V600E, is a molecular biomarker for papillary thyroid cancer (PTC)—that can confirm the presence and type of cancer cells. Researchers have developed a new, rapid method for direct detection of the BRAF V600E gene in thyroid tissue without the need to purify DNA from tumor cells—high resolution melting analysis.
› Verified 9 days ago